Clinical manifestations of temporal arteritis: A report from Israel

Journal of Rheumatology

Volumn 23, Issue 11, 1996, Pages 1927-1931

  Gur, Hanan ^a,d   Rapman, Edward ^b   Ehrenfeld, Michael ^c   Sidi, Yechezkel ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b Department of Medicine C ^*  (Israel)

^c Department of Medicine C

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Giant cell arteritis; Temporal arteritis; Vasculitis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HEADACHE; HUMAN; ISRAEL; MALE; MORBIDITY; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERITIS;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; HEADACHE; HUMANS; ISRAEL; JEWS; LIVER FUNCTION TESTS; LUNG DISEASES; MALE; MIDDLE AGED; TEMPORAL ARTERITIS;

EID: 0029917350     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Weyand CM, Goronzy JJ: Molecular approaches toward pathologic mechanism in giant cell arteritis and Takayasu's arteritis. Curr Opin Rheumatol 1995;7:30-6.
2. Lie JT, American College of Rheumatology Subcommittee on Classification of Vasculitis: Illustrated Histopathologic Classification Criteria for Selected Vasculitis Syndromes. Arthritis Rheum 1990;3:1074-87.
3. Banks PM, Cohen MD, Ginsburg WW, Hunder GG: Immunohistologic and cytochemical studies of temporal arteritis. Arthritis Rheum 1983;26:1201-7.
4. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR: Temporal arteritis: A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162-7.
5. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ: Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121:484-91.
6. Fainaru M, Friedman G, Friedman B: Temporal arteritis in Israel. A review of 47 patients. J Rheumatol 1979;6:330-5.
7. Friedman G, Friedman B, Benbassat J: Epidemiology of temporal arteritis in Israel. Isr J Med Sci 1982;18:241-4.
8. Machado EBV, Michel CJ, Ballard DJ, et al: Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-9.
9. Nordborg E, Bengtsson BA: Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med 1990;227:233-6.
10. Sonnenblick M, Nesher G, Rosin A: Nonclassical organ involvement in temporal arteritis. Semin Arthritis Rheum 1989;19:183-90.
11. Desmet GD, Knockaert DC, Bobbaers HJ: Temporal arteritis: The silent presentation and delay in diagnosis. J Intern Med 1990;27:237-40.
12. Healey LA, Wilske HR: Presentation of occult giant cell arteritis. Arthritis Rheum 1980;23:641-3.
13. Wilke WS, Wysenbeek A, Krall PL, Segal AM: Masked presentation of giant-cell arteritis. Cleve Clin Q 1985;52:155-9.
14. Hunder GG, Bloch DA, Michel BA, et at: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
15. Altman DG: Practical Statistics for Medical Research. London: Chapman & Hall, 1991.
16. Gabriel SE, O'Fallon WM, Achkar AA, Lie JT, Hunder GC The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol 1995;22:93-6.
17. Rajale SA, Ahvenainen JE, Mattila KJ, Saarni MI: Incidence and survival rates in cases of biopsy-proven temporal arteritis. Scand J Rheumatol 1993;22:289-91.
18. Hunder GG, Lie JT, Goronzy JJ, Weyand CM: Pathogenesis of giant cell arteritis. Arthritis Rheum 1993;36:757-61.
19. Barrier J, Pion P, Massari R, Peltier P, Rojouan J, Grolleau JY: Epidemiologic approach to Morion's disease in the Department of Loire-Atlantique: 110 cases in 10 years (1970-1979). Rev Med Interne 1983;3:13-20.
20. Smith CA, Fidler WJ, Pinals RS: The epidemiology of giant cell arteritis: Report of a 10-year study in Shelby County, Tennessee. Arthritis Rheum 1983;26:1214-9.
21. Boesen P, Sorensen SF: Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: A prospective investigation, 1982-1985. Arthritis Rheum 1987;30:294-9.
22. Salvarani C, Macchioni P, Zizza F, et al: Epidemiologic and immunogenetic studies of aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum 1991;34:351-6.
23. Richardson JE, Gladman DD, Fam A, Keystone EC: HLA-DR4 in giant cell arteritis: Association with polymyalgia rheumatica syndrome. Arthritis Rheum 1987;30:1293-7.
24. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ: The HLA-DRB locus as a genetic component in giant cell arteritis: Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest 1992;90:2355-61.
25. Jonasson F, Cullen JF, Elton RA: Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. Scott Med J 1979;24:11-7.
26. Andersson R, Malmvall BE, Bengtsson BA: Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acta Med Scand 1986,-220:361-5.
27. Hauser WA, Ferguson RH, Holley KE, Kurland LT: Temporal arteritis in Rochester, Minnesota, 1951-1967. Mayo Clin Proc 1971;46:597-602.
28. Rubinow A, Brandt KD, Cohen AS, Sach B: Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids. Ann Ophthalmol 1984;16:258-65.
29. Bisgard C, Sloth H, Keiding N, Juel K: Excess mortality in giant cell arteritis. J Intern Med 1991;230:119-23.
30. Nesher G, Sonnenblick M, Friedlander Y: Analysis of steroid related complications and mortality in temporal arteritis: A 15-year survey of 43 patients. J Rheumatol 1994;21:1283-6.
31. Thomas RD, Croft DN: Thyrotoxicosis and giant cell arteritis. BMJ 1974;2:408-9.
32. Dent RG, Edwards OM: Autoimmune thyroid disease and the polymyalgia rheumatica-giant cell arteritis syndrome. Clin Endocrinol (Oxf)1978;9:215-19.
33. Haga HJ, Eide GE, Brun J, Johansen A, Langmark F: Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993;20:1335-9.
34. Bengtsson B, Malmvall B: The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Arthritis Rheum 1981;24:899-904.
35. Larson TS, Hall S, Hepper NGG, Hunder GG: Respiratory tract symptoms as a clue to giant cell arteritis. Ann Intern Med 1984;101:594-7.
36. Dickson ER. Maldonado JE, Sheps SG, Caine JA: Systemic temporal arteritis and polymyalgia rheumatica. Reversible abnormalities of liver functions. JAMA 1973;224:1496-8.